Hamid Harandi

Dr. Hamid Harandi

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2024 in Human Brain Mapping
Verified
Journal Article
Open access
MSMohammad Amin Salehi
Mohammad Amin Salehi
RZRasa Zafari
Rasa Zafari
SMSoheil Mohammadi
Soheil Mohammadi
MFMohammad Shahrabi Farahani
Mohammad Shahrabi Farahani
MDMahsa Dolatshahi
Mahsa Dolatshahi
SDStephen R. Dager
Stephen R. Dager
Schizophrenia is a chronic psychiatric disorder with characteristic symptoms of delusions, hallucinations, lack of motivation, and paucity of thought. Recent evidence suggests that the symptoms of schizophrenia, negative symptoms in particular, vary widely between the sexes and that symptom onset is earlier in males. A better understanding of sex‐based differences in functional magnetic resonance imaging (fMRI) studies of schizophrenia may provide a key to understanding sex‐based symptom differences. This study aimed to summarize sex‐based functional magnetic resonance imaging (fMRI) differences in brain activity of patients with schizophrenia. We searched PubMed and Scopus to find fMRI studies that assessed sex‐based differences in the brain activity of patients with schizophrenia. We excluded studies that did not evaluate brain activity using fMRI, did not evaluate sex differences, and were nonhuman or in vitro studies. We found 12 studies that met the inclusion criteria for the current systematic review. Compared to females with schizophrenia, males with schizophrenia showed more blood oxygen level‐dependent (BOLD) activation in the cerebellum, the temporal gyrus, and the right precuneus cortex. Male patients also had greater occurrence of low‐frequency fluctuations in cerebral blood flow in frontal and parietal lobes and the insular cortex, while female patients had greater occurrence of low‐frequency fluctuations in the hippocampus, parahippocampus, and lentiform nucleus. The current study summarizes fMRI studies that evaluated sex‐based fMRI brain differences in schizophrenia that may help to shed light on the underlying pathophysiology and further understanding of sex‐based differences in the clinical presentation and course of the disorder.

13 May 2026 in Seminars in Arthritis and Rheumatism
Verified
Journal Article
Closed access
SMSoheil Mohammadi
Soheil Mohammadi
HHHamid Harandi
Hamid Harandi
SASogol Alikarami
Sogol Alikarami
SFSajjad Fattahniya
Sajjad Fattahniya
RSReza Samiee
Reza Samiee
AGAli Guermazi
Ali Guermazi

24 November 2025 in Journal of Clinical Ultrasound
Verified
Journal Article
Closed access
SASogol Alikarami
Sogol Alikarami
HHHamid Harandi
Hamid Harandi
AJAli Jahanshahi
Ali Jahanshahi
SZSeyed Sina Zakavi
Seyed Sina Zakavi
NFNegin Frounchi
Negin Frounchi
SMSara Momtazmanesh
Sara Momtazmanesh

9 June 2025 in Osteoarthritis Imaging
Verified
Journal Article
Open access
HHHamid Harandi
Hamid Harandi
SMSoheil Mohammadi
Soheil Mohammadi
AGAli Guermazi
Ali Guermazi
This paper provides a comprehensive overview of the key themes, new findings, and research directions highlighted during the keynote presentations and panel discussions at the IWOAI 2024. Comprehensive literature review of keynote lectures and submitted scientific abstracts presented during the 18th IWOAI held in Marrakesh, Morocco. The 18th International Workshop on Osteoarthritis Imaging (IWOAI) was held from June 25 to June 28, 2024, in Marrakesh, Morocco. The main theme of the workshop was Structure and Pain: Where Are We Today? Ten sessions covering various aspects of new concepts and strategies related to structure and pain in the imaging of osteoarthritis (OA) were held. These sessions included nine keynote presentations and oral presentations of abstracts, addressing different topics such as structural factors in OA, pain management challenges in OA-related trials, and imaging outcomes as endpoints in these trials. The final session was a round table featuring participants from diverse scientific and clinical fields who discussed their perspectives on the utility of imaging in OA. The meeting successfully informed the radiology community about current advances, research, and future directions in osteoarthritis-related structure and pain through keynote speeches and oral presentations.

11 September 2024 in medRxiv
Verified
Preprint
Open access
PDF file
SASogol Alikarami
Sogol Alikarami
HHHamid Harandi
Hamid Harandi
AJAli Jahanshahi
Ali Jahanshahi
SZSeyed Sina Zakavi
Seyed Sina Zakavi
NFNegin Frounchi
Negin Frounchi
SMSara Momtazmanesh
Sara Momtazmanesh
Background In recent years, the tumor management strategies have focused on less invasive methods, aiming to yield optimal efficacy while minimizing further complications and enhancing the overall outcome of patients. High-intensity focused ultrasound (HIFU), a known thermal ablative technique, has shown promising results in breast cancer treatment. Therefore, we performed this systematic review and meta-analysis to assess the clinical, histopathologic, immunologic, and radiologic outcomes of HIFU ablative therapy and its complications in patients with primary breast cancer. Methods We searched PubMed and Scopus databases to identify the eligible articles. Data extraction was conducted by two independent authors. A random effect model was employed to pool the proportion of remaining tumor after HIFU therapy in breast cancer. Pooled CD4/CD8 ratio mean difference between HIFU and radical mastectomy was, measured using a fixed-effect model. Results We included 26 studies and 677 participants in the systematic review. Tumor necrosis rates varied, with 4 studies reporting less than 50% complete necrosis and 5 more than 50%. Two studies observed HIFU-induced disturbances in microvasculature of the targeted tissue. Six noted no contrast enhancement in successfully treated areas, two observed a thin rim indicating necrosis or fibrosis, and four reported a persistent enhancement in MRI images associated with a residual viable tumor. The weighted proportion of patients with residual tumor was 58.45 (95% C: 45.48 – 71.42). The CD4/CD8 ratio was higher in the HIFU group, with a weighted mean difference of 0.6 (95% CI: 0.41 – 0.78). The most prevalent side effects were pain (47.14%) and skin burn (2.59%). Conclusions HIFU is a relatively safe procedure for treatment of breast cancer as an independent or conjugated therapy and its effectiveness is promising regarding histopathological response, immunological reactivity, and vascular damage in the targeted area.

1 August 2026 in Radiology
Verified
Journal Article
Closed access
MJMohamed Jarraya
Mohamed Jarraya
HHHamid Harandi
Hamid Harandi